Clinical trial MK3475-587
A Multicenter, Open Label, Phase III Extension Trial to study the Long-term Safety and Efficacy in Participants with Advanced Tumors who are currently on Treatment or in Follow-up in a Pembrolizumab Trial (MK3475-587)
| Organ | Multiple |
|---|---|
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | MSD (Merck Sharp & Dohme) |
| EudraCT Identifier | 2017-004417-42 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03486873 |
| Inclusion criteria | Roll-over of other trials with pembrolizumab |
| Last update |